iTeos Therapeutics (ITOS) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free ITOS Stock Alerts $17.44 +5.25 (+43.07%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineITeos Therapeutics Shares Surge 47% After Promising Tumor Treatment Datamarketwatch.com - May 10 at 7:31 PMiTeos Therapeutics (NASDAQ:ITOS) Shares Gap Up to $12.19marketbeat.com - May 10 at 6:33 PMiTeos Therapeutics Inc.: iTeos Reports First Quarter 2024 Financial Results and Provides Business Updatesfinanznachrichten.de - May 10 at 9:07 AMiTeos Therapeutics Inc.: iTeos Therapeutics Announces $120 Million Registered Direct Offeringfinanznachrichten.de - May 10 at 9:07 AMiTeos Reports First Quarter 2024 Financial Results and Provides Business Updatesglobenewswire.com - May 10 at 8:26 AMiTeos Therapeutics Announces $120 Million Registered Direct Offeringglobenewswire.com - May 10 at 8:24 AMADC Therapeutics Non-GAAP EPS of -$0.38, revenue of $17.8M misses by $0.32Mseekingalpha.com - May 6 at 4:07 PMIteos Therapeutics Inc (ITOS)investing.com - April 16 at 2:54 PMiTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024globenewswire.com - April 7 at 4:30 PMiTeos Therapeutics, Inc. (NASDAQ:ITOS) Sees Significant Increase in Short Interestmarketbeat.com - April 1 at 7:41 AMAnalysts Offer Insights on Healthcare Companies: iTeos Therapeutics (ITOS), Rani Therapeutics Holdings (RANI) and Vor Biopharma (VOR)markets.businessinsider.com - March 22 at 12:32 AMCitigroup Inc. Sells 148,333 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS)marketbeat.com - March 19 at 4:59 AMiTeos Therapeutics, Inc. (NASDAQ:ITOS) Sees Large Growth in Short Interestmarketbeat.com - March 18 at 2:46 PMITOS Oct 2024 17.000 callfinance.yahoo.com - March 11 at 10:51 PMAnalysts Are Bullish on These Healthcare Stocks: iTeos Therapeutics (ITOS), Viracta Therapeutics (VIRX)markets.businessinsider.com - March 11 at 7:44 AMiTeos Therapeutics, Inc. to Post Q1 2024 Earnings of ($1.22) Per Share, HC Wainwright Forecasts (NASDAQ:ITOS)marketbeat.com - March 11 at 1:48 AMITOS Oct 2024 12.000 callfinance.yahoo.com - March 10 at 8:36 PMITOS Mar 2024 4.000 putfinance.yahoo.com - March 10 at 3:35 PMHC Wainwright Comments on iTeos Therapeutics, Inc.'s FY2027 Earnings (NASDAQ:ITOS)marketbeat.com - March 8 at 7:22 AMiTeos Therapeutics (NASDAQ:ITOS) Posts Earnings Results, Beats Expectations By $0.18 EPSmarketbeat.com - March 7 at 10:11 AMiTeos Therapeutics' (ITOS) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - March 7 at 8:21 AMiTeos Therapeutics Inc.: iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatesfinanznachrichten.de - March 6 at 7:39 PMITOS Mar 2024 11.000 callfinance.yahoo.com - March 6 at 7:39 PMiTeos Therapeutics (NASDAQ:ITOS) Given "Outperform" Rating at Wedbushmarketbeat.com - March 6 at 11:55 AMiTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directorsglobenewswire.com - March 6 at 7:01 AMiTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatesglobenewswire.com - March 6 at 7:00 AMiTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024globenewswire.com - March 5 at 4:30 PM683 Capital Management LLC Purchases 225,000 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS)marketbeat.com - March 1 at 10:35 AMiTeos to Participate in Upcoming Investor Conferencesglobenewswire.com - March 1 at 7:00 AMDeerfield Management Company L.P. Series C Makes New Investment in iTeos Therapeutics, Inc. (NASDAQ:ITOS)marketbeat.com - February 28 at 2:12 PMiTeos Therapeutics, Inc. (NASDAQ:ITOS) Sees Significant Growth in Short Interestmarketbeat.com - February 16 at 8:19 PMiTeos Therapeutics (NASDAQ:ITOS) Receives Outperform Rating from Wedbushmarketbeat.com - January 8 at 6:27 PMiTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 3 at 9:50 AMShort Interest in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Expands By 17.3%marketbeat.com - January 1 at 12:16 PMWall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 243.43%: Here's is How to Tradefinance.yahoo.com - December 13 at 3:54 PMiTeos Therapeutics (NASDAQ: ITOS)fool.com - November 29 at 10:23 AMDoes iTeos Therapeutics, Inc. (ITOS) Have the Potential to Rally 283.59% as Wall Street Analysts Expect?finance.yahoo.com - November 27 at 4:57 PMiTeos to Present at the Piper Sandler 35th Annual Healthcare Conferencefinance.yahoo.com - November 21 at 9:28 AMiTeos Therapeutics’ Anticipated Growth and Clinical Updates Drive Buy Rating: An Analyst’s Perspectivemarkets.businessinsider.com - November 14 at 11:38 PMHere's Why iTeos Therapeutics, Inc. (ITOS) Could be Great Choice for a Bottom Fisherfinance.yahoo.com - November 13 at 3:00 PMWall Street Analysts Predict a 304.26% Upside in iTeos Therapeutics, Inc. (ITOS): Here's What You Should Knowfinance.yahoo.com - November 10 at 1:58 PMWall Street Analysts Predict a 304.26% Upside in iTeos Therapeutics, Inc. (ITOS): Here's What You Should Knowfinance.yahoo.com - November 10 at 1:58 PMPositive Financial Results and Promising Cancer Treatment Programs Underpin Buy Rating for iTeos Therapeuticsmarkets.businessinsider.com - November 9 at 12:20 AMiTeos Reports Third Quarter 2023 Financial Results and Provides Business Updatesfinance.yahoo.com - November 7 at 9:48 AMViridian Therapeutics, Inc. (VRDN) Stock Jumps 5.2%: Will It Continue to Soar?finance.yahoo.com - October 31 at 4:58 AMWedbush Reiterates ITeos Therapeutics (ITOS) Outperform Recommendationmsn.com - October 19 at 6:46 PMiTeos Therapeutics, Inc. (ITOS) Stock Jumps 5.4%: Will It Continue to Soar?finance.yahoo.com - October 16 at 7:36 AMS&P Dow Jones Indices: NCR Atleos Set to Join S&P SmallCap 600finanznachrichten.de - October 12 at 8:54 AMFY2026 Earnings Estimate for iTeos Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:ITOS)marketbeat.com - September 29 at 8:15 AMiTeos Therapeutics, Inc. (NASDAQ:ITOS) Short Interest Up 5.9% in Augustmarketbeat.com - September 19 at 5:41 AM Get iTeos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ITOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ITOS Media Mentions By Week ITOS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ITOS News Sentiment▼0.090.55▲Average Medical News Sentiment ITOS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ITOS Articles This Week▼81▲ITOS Articles Average Week Get iTeos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ITOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LXEO News Today FATE News Today ALVO News Today ADPT News Today REPL News Today TSHA News Today EDIT News Today CCCC News Today TCRX News Today VYGR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ITOS) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithCollapse of the Petrodollar Colonial MetalsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iTeos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
